Angiotensin receptor-neprilysin inhibitor-based therapy among adult heart failure patients with below normal systemic ventricular ejection fraction and complex congenital heart disease

Back

ESC2025 Premium Access

Angiotensin receptor-neprilysin inhibitor-based therapy among adult heart failure patients with below normal systemic ventricular ejection fraction and complex congenital heart disease

Session: Heart failure management in specific populations

Topic: Pharmacotherapy

Speaker: Doctor D. Dela Cruz (Metro Manila, PH)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Dastynne Marie Dela Cruz

St. Luke's Medical Center Global City, Metro Manila (Philippines)

0 follower

9 more presentations in this session

Efficacy of sodium-glucose cotransporter 2 inhibitors for super-aged heart failure population

Speaker: Doctor J. Noiri (Kobe, JP)

Phenotypes of heart failure with preserved ejection fraction and effect of sodium-glucose cotransporter 2 inhibitors treatment

Speaker: Doctor A. Sezaki (Tokyo, JP)

The relevant role of frailty in patients with transthyretin amyloidosis cardiomyopathy

Speaker: Doctor B. Dal Passo (Ferrara, IT)

Role of comorbidities and weight variations in the survival of diabetic patients with heart failure

Speaker: Professor O. Hanon (Paris, FR)

The effects of empagliflozin on ventricular arrhythmias in heart failure patients with an implantable cardioverter-defibrillator: a systematic review

Speaker: Doctor M. Hunjul (Nablus, PS)

Access the full session

Heart failure management in specific populations

Speakers: Doctor D. Dela Cruz, Doctor J. Noiri, Doctor A. Sezaki, Doctor B. Dal Passo, Professor O. Hanon...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources